XML 22 R12.htm IDEA: XBRL DOCUMENT
v3.22.1

Prepaid Expenses and Other Current Assets | 3 Months Ended
--- | ---
Mar. 31, 2022
Prepaid Expenses And Other Current Assets [Abstract] |
Prepaid Expenses and Other Current Assets | 5. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in $000s):
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, | ​ | December 31,
​ |  | 2022 |  | 2021
Research and development tax credit receivable | ​ | $ | 4,732 | ​ | $ | 3,727
Prepayments and VAT receivable | ​ | ​ | 667 | ​ |  | 577
Other current assets | ​ |  | 1,539 | ​ | ​ | 79
​ | ​ | $ | 6,938 | ​ | $ | 4,383
​ Receivables of $1.3 million are included in other current assets as of March 31, 2022. This relates to royalty payments receivable under a December 2005 Asset Purchase Agreement, or APA, whereby Xcyte Therapies, Inc., or Xcyte, (a business acquired by the Company in March 2006) sold certain assets and intellectual property to Thermo Fisher Scientific Company, or TSC, (formerly Invitrogen Corporation) through the APA and other related agreements. The assets and technology were not part of the Company’s product development plan following the transaction between Xcyte and Cyclacel in March 2006. Accordingly, the Company recognized $1.3 million of other income related to this transaction during the three months ended March 31, 2022.

X
- References No definition available. + Details
Name: | cycc_PrepaidExpensesAndOtherCurrentAssetsAbstract
Namespace Prefix: | cycc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition This element represent as Prepaid Expenses and Other Current Assets. + References No definition available. + Details
Name: | cycc_PrepaidExpensesAndOtherCurrentAssetsTextBlock
Namespace Prefix: | cycc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration